These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9286472)

  • 21. [Current problems of glucocorticoid therapy in neurology].
    Berlit P
    Med Klin (Munich); 1993 Jan; 88 Suppl 1():9-11. PubMed ID: 8437539
    [No Abstract]   [Full Text] [Related]  

  • 22. [Glucocorticoid therapy in internal medicine. I].
    Medau HJ
    Med Welt; 1973 Sep; 24(38):1427-30. PubMed ID: 4587963
    [No Abstract]   [Full Text] [Related]  

  • 23. Low dose glucocorticoid therapy in rheumatoid arthritis (RA): transitional or selected add-on therapy?
    Masi AT
    J Rheumatol; 1983 Oct; 10(5):675-8. PubMed ID: 6227745
    [No Abstract]   [Full Text] [Related]  

  • 24. Glucocorticoid sensitivity in inflammatory bowel disease.
    Sidoroff M; Kolho KL
    Ann Med; 2012 Sep; 44(6):578-87. PubMed ID: 21992564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: a meta-analysis.
    Ravindran V; Rachapalli S; Choy EH
    Rheumatology (Oxford); 2009 Jul; 48(7):807-11. PubMed ID: 19447767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of glucocorticoid therapy on the adrenal cortex function in children with neurodermatitis].
    Zver'kova FA; Miliavskaia IR
    Vestn Dermatol Venerol; 1984 Oct; (10):43-6. PubMed ID: 6516573
    [No Abstract]   [Full Text] [Related]  

  • 27. [Glucocorticoid therapy for rheumatoid arthritis].
    Treves R; Bertin P
    Ann Med Interne (Paris); 2002 Feb; 153(1):53-60. PubMed ID: 11994690
    [No Abstract]   [Full Text] [Related]  

  • 28. What to do for moderate-to-severe and active Graves' orbitopathy if glucocorticoids fail?
    Bartalena L
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):149-52. PubMed ID: 20148907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoids and cardiovascular risk factors.
    Strohmayer EA; Krakoff LR
    Endocrinol Metab Clin North Am; 2011 Jun; 40(2):409-17, ix. PubMed ID: 21565675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocorticoid-induced diabetic ketoacidosis in acute rheumatic fever.
    Cağdaş DN; Paç FA; Cakal E
    J Cardiovasc Pharmacol Ther; 2008 Dec; 13(4):298-300. PubMed ID: 19087951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth, bone mineral accretion, and adrenal function in glucocorticoid-treated infants with hemangiomas-- a retrospective study.
    Lomenick JP; Backeljauw PF; Lucky AW
    Pediatr Dermatol; 2006; 23(2):169-74. PubMed ID: 16650230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating adiponectin as a marker for glucocorticoid-related side effects in children and adolescents with inflammatory bowel disease.
    Vihinen MK; Kolho KL; Jänne OA; Andersson S; Raivio T
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48(4):504-6. PubMed ID: 19322063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis.
    Kirwan J; Power L
    Curr Opin Rheumatol; 2007 May; 19(3):233-7. PubMed ID: 17414948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preadmission use of systemic glucocorticoids and 30-day mortality following bleeding peptic ulcer: a population-based cohort study.
    Olsen M; Christensen S; Riis A; Thomsen RW
    Am J Ther; 2010; 17(1):23-9. PubMed ID: 19531935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.
    Schäcke H; Berger M; Rehwinkel H; Asadullah K
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):109-17. PubMed ID: 17630119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in glucocorticoid therapy.
    Baxter JD
    Adv Intern Med; 2000; 45():317-49. PubMed ID: 10635054
    [No Abstract]   [Full Text] [Related]  

  • 37. Endocrine and other physiological derangements following long-term glucocorticoid therapy.
    Liddle GW
    Chronobiologia; 1974 Sep; 1 Suppl 1():237-47. PubMed ID: 4377959
    [No Abstract]   [Full Text] [Related]  

  • 38. The epidemiology of glucocorticoid-associated adverse events.
    McDonough AK; Curtis JR; Saag KG
    Curr Opin Rheumatol; 2008 Mar; 20(2):131-7. PubMed ID: 18349741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analytic studies of blood coagulation in patients with ecchymoses in glucocorticoid therapy].
    Lutze G; Lottmann S
    Z Arztl Fortbild (Jena); 1986; 80(22):939-40. PubMed ID: 3564561
    [No Abstract]   [Full Text] [Related]  

  • 40. Perioperative glucocorticoids in hip and knee surgery - benefit vs. harm? A review of randomized clinical trials.
    Lunn TH; Kehlet H
    Acta Anaesthesiol Scand; 2013 Aug; 57(7):823-34. PubMed ID: 23581549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.